It may help you stay full for longer periods of the day and cut back your cravings for unhealthy snacks, allowing you to create a healthier way of living
Most patients report that nausea peaks around day 35 after injection and resolves within 57 days as tolerance builds
Tirzepatide, an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and obesity, works through incretin-based glucose regulation and appetite suppression
This review advances the argument that progress in oral peptide and protein therapeutics requires a conceptual shift from platform-driven optimism to pharmacology-driven exclusion
Semaglutide has demonstrated cardiovascular benefits in clinical trials (SELECT trial), reducing the risk of major adverse cardiovascular events, though this is not currently part of Wegovy's licensed indication in the UK
While both medications contain the same active ingredient, semaglutide, their different forms of administration offer flexibility depending on a persons preference for daily versus weekly dosing and tablet versus injection form
